What are the risks of stroke in the postpartum period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

After experiencing a stroke during pregnancy, patients should be on a comprehensive treatment plan that prioritizes blood pressure control, lifestyle modifications, and regular follow-ups to minimize the risk of recurrent stroke and improve long-term outcomes. The risk of stroke is approximately tripled in pregnant and postpartum individuals compared to young adults of similar age, with the highest-risk time point being the early postpartum period 1.

Key Considerations

  • Blood pressure should be maintained below 140/90 mmHg using pregnancy-safe medications like labetalol or nifedipine if needed 1.
  • Lifestyle modifications are crucial, including a heart-healthy diet, regular physical activity as tolerated, smoking cessation, and limiting alcohol consumption.
  • Regular neurological follow-ups every 3-6 months in the first year post-stroke are essential, along with monitoring by a high-risk obstetrician for any future pregnancies.
  • Preconception counseling is strongly recommended for future pregnancies, and anticoagulation therapy may be considered depending on stroke etiology.

Management and Prevention

  • The mechanisms of pregnancy-associated stroke are diverse, and the sequelae can be catastrophic 1.
  • Additional risk factors for maternal stroke include older age, migraine, assisted reproductive technology, obesity, heart disease, infections, and SLE 1.
  • Evidence supports BP control as critical for the prevention of maternal morbidity, including fatal and nonfatal stroke 1.
  • Patients with hypertensive disorders in pregnancy (HDP) represent a particularly high-risk group for maternal stroke, and intracerebral hemorrhage (ICH) is a leading cause of death in these individuals 1.

Treatment and Follow-up

  • Antiplatelet therapy such as low-dose aspirin (81-100mg daily) may be considered indefinitely, unless contraindicated, as part of a comprehensive treatment plan.
  • The risk of recurrent stroke is highest in the first year after the initial event, with pregnancy itself being a hypercoagulable state that increases stroke risk due to hormonal changes, increased blood volume, and changes in blood vessel reactivity 1.
  • Early intervention and adherence to the treatment plan significantly improve long-term outcomes and reduce recurrence risk.

From the Research

Strokes in Pregnancy Afterwards

  • The risk of ischemic stroke is elevated especially from the third trimester until 6 weeks postpartum 2.
  • Pregnancy and the postpartum period confer an increased risk of stroke, with the risk appearing to be increased for all strokes during the puerperium and for hemorrhagic strokes during pregnancy 3.
  • The common independent vascular risk factors for stroke, such as hypertension, diabetes, hyperlipidemia, and smoking, may also be present to contribute to the risks conferred by pregnancy 3.
  • Ischemic stroke during pregnancy or the puerperium is a devastating disease during a crucial period in life and warrants a specific approach, with current practice mainly based on expert opinion due to a lack of randomized controlled trials and high-quality observational studies 2.

Management of Strokes in Pregnancy

  • MRI is the most accurate and well tolerated diagnostic option, but low-dose CT-head is a valid alternative 2.
  • Reperfusion therapies should not be withheld from a pregnant woman with moderate-to-severe stroke when benefits outweigh the risk 2.
  • Aspirin up to 150 mg daily is considered well tolerated during pregnancy and lactation period 2.
  • Acute stroke in pregnancy can be devastating, and obstetric care providers should have an understanding of the presentation and management of stroke, particularly in the initial period when the window of opportunity for therapy is critical 4.

Clinical Presentation and Management

  • Patients presenting within 4.5 hours of symptom onset and with an initial normal head CT scan are candidates for alteplase (tissue plasminogen activator [tPA]) 4.
  • Blood pressure control is paramount when administering tPA, with a recommended range of 140-160/90-110 mm Hg during tPA treatment 4.
  • Pregnancy should not be a contraindication for mechanical thrombectomy in carefully selected patients 4.
  • Supportive therapy should include aggressive treatment of fever, avoidance of hypotonic maintenance fluids, and maintenance of normal serum sodium levels 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Stroke in Pregnancy.

Seminars in neurology, 2017

Research

Acute Management of Ischemic Stroke During Pregnancy.

Obstetrics and gynecology, 2019

Related Questions

What is the antiplatelet therapy for acute stroke in pregnancy?
What is the best radiographic test to confirm a diagnosis of acute ischemic stroke in a patient with sudden onset of right-sided weakness and neurological deficits?
What is the first imaging order for a patient presenting with acute-onset left-sided weakness and facial droop, suspected of having a stroke?
What is the initial management approach for a patient suspected of having an Acute Vascular Cerebral event (AVC) or stroke?
What is the 90-day mortality rate for patients following a cerebrovascular accident (stroke)?
Is urinary incontinence common in patients with syncope (fainting)?
What drugs cause uremia (azotemia, impaired renal function)?
What is the most appropriate management for a patient with hyponatremia (serum sodium level of 130 milliequivalents per liter (mEq/L)) and symptoms of headache, confusion, and disorientation after participating in a marathon?
What is mixed dyslipidemia (Mixed Hyperlipidemia)?
What is the most appropriate management for a 54-year-old woman with hypertension, chronic kidney disease (CKD), and impaired renal function, who developed hyperkalemia and worsening renal function after initiating lisinopril (angiotensin-converting enzyme inhibitor) and is currently on amlodipine (calcium channel blocker)?
What is the most likely diagnosis for a 35-year-old woman with recurrent microscopic hematuria (presence of blood in urine), normal serum creatinine level, and a family history of microscopic hematuria, with no proteinuria (presence of excess proteins in urine) or chronic kidney disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.